Assignee
XIAMEN HANLIXIN PHARMACEUTICAL CO LTD
CN·0 granted patents·2 pending applications·0 citations·filing 2023–2024
Top patents by PatentIndex Score
2 records- 0153US2025205208A1Use of su3327 in preparation of medicament for reducing cytotoxicity and nephrotoxicity of polymyxinXIAMEN HANLIXIN PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0252US2025170106A1Use of su3327 in preparation of medicament for enhancing efficacy of polymyxin against bacterial infectionXIAMEN HANLIXIN PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when XIAMEN HANLIXIN PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →